Form 4: Veracyte SVP Sells 2,160 Shares Under 10b5-1 Plan

Veracyte, Inc. SVP and General Counsel Annie McGuire reported the sale of 2,160 shares of common stock at an average price of $35.0035 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Annie McGuire, SVP, General Counsel of Veracyte, Inc. (VCYT), reported a sale of common stock.
• The transaction involved the disposition of 2,160 shares of VCYT common stock.
• The shares were sold on October 1, 2025, at a weighted average price of $35.0035 per share.
• Sale prices for the transactions ranged from $35.00 to $35.05 per share.
• Following this transaction, Annie McGuire beneficially owns 89,439 shares of Veracyte common stock.
• The sale was conducted pursuant to a Rule 10b5-1 plan adopted by Ms. McGuire on September 4, 2024.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan, which is generally considered neutral as it is not indicative of new material information or a change in company fundamentals.

Future Outlook

N/A

Industry Context

N/A

Related Party Transactions

• The transaction involves an insider (SVP, General Counsel) selling company stock, which is a form of related party transaction in the context of beneficial ownership disclosure.

Stakeholder Impact

• The sale of a relatively small number of shares by an SVP under a pre-arranged plan is unlikely to have a significant direct impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Keywords

Veracyte, VCYT, Insider Trading, Form 4, Stock Sale, Annie McGuire, 10b5-1 Plan, Officer Transaction, Equity Disclosure